L T Foods Ltd
LT Foods Limited was incorporated in the 1980's. It is primarily engaged in the business of milling, processing and marketing of branded and non-branded basmati rice and manufacturing of rice food products in the domestic and overseas market.
It is also engaged in research and development to add value to rice and rice food products. The Company’s rice product portfolio comprises brown rice, white rice, steamed rice, parboiled rice, organic rice, quick cooking rice, value added rice and flavored rice in the ready to cook segment.
The Company’s subsidiary, Nature Bio Foods Limited (NBFL) drives the ingredient based organic food segment. It has emerged as a trusted brand, offering authentic organic ingredients to consumers across the markets of the US and Europe. [1]
- Market Cap ₹ 12,213 Cr.
- Current Price ₹ 351
- High / Low ₹ 448 / 160
- Stock P/E 63.3
- Book Value ₹ 51.0
- Dividend Yield 0.43 %
- ROCE 13.6 %
- ROE 9.78 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 20.3%
Cons
- Stock is trading at 6.90 times its book value
- Company has a low return on equity of 11.0% over last 3 years.
- Promoter holding has decreased over last 3 years: -5.81%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Food - Processing - Indian
Part of Nifty Microcap 250 BSE Allcap BSE SmallCap BSE Fast Moving Consumer Goods Nifty Total Market
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1,654 | 1,793 | 1,808 | 1,814 | 2,052 | 2,139 | 2,193 | 2,350 | 2,383 | 2,840 | 3,915 | 4,020 | 4,095 | |
1,512 | 1,651 | 1,681 | 1,676 | 1,899 | 2,000 | 2,025 | 2,178 | 2,199 | 2,660 | 3,688 | 3,781 | 3,832 | |
Operating Profit | 142 | 142 | 127 | 138 | 153 | 140 | 168 | 172 | 184 | 180 | 227 | 239 | 263 |
OPM % | 9% | 8% | 7% | 8% | 7% | 7% | 8% | 7% | 8% | 6% | 6% | 6% | 6% |
8 | 8 | 34 | 26 | 24 | 17 | 15 | 27 | 22 | 24 | 37 | 29 | 45 | |
Interest | 82 | 72 | 90 | 91 | 107 | 85 | 76 | 60 | 34 | 23 | 24 | 19 | 18 |
Depreciation | 23 | 22 | 29 | 26 | 23 | 18 | 23 | 26 | 26 | 32 | 29 | 39 | 39 |
Profit before tax | 44 | 57 | 43 | 47 | 47 | 54 | 83 | 113 | 146 | 149 | 211 | 211 | 250 |
Tax % | 23% | 32% | 28% | 35% | 37% | 22% | 35% | 24% | 27% | 25% | 24% | 24% | |
34 | 38 | 31 | 30 | 30 | 42 | 54 | 85 | 106 | 112 | 160 | 160 | 193 | |
EPS in Rs | 1.29 | 1.46 | 1.16 | 1.14 | 1.12 | 1.31 | 1.70 | 2.66 | 3.33 | 3.51 | 4.62 | 4.60 | 5.56 |
Dividend Payout % | 15% | 15% | 17% | 13% | 13% | 11% | 9% | 19% | 30% | 28% | 22% | 11% |
Compounded Sales Growth | |
---|---|
10 Years: | 8% |
5 Years: | 13% |
3 Years: | 19% |
TTM: | 8% |
Compounded Profit Growth | |
---|---|
10 Years: | 15% |
5 Years: | 23% |
3 Years: | 14% |
TTM: | 12% |
Stock Price CAGR | |
---|---|
10 Years: | 41% |
5 Years: | 73% |
3 Years: | 75% |
1 Year: | 69% |
Return on Equity | |
---|---|
10 Years: | 10% |
5 Years: | 11% |
3 Years: | 11% |
Last Year: | 10% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 26 | 26 | 26 | 27 | 27 | 32 | 32 | 32 | 32 | 32 | 35 | 35 | 35 |
Reserves | 219 | 251 | 276 | 302 | 337 | 749 | 810 | 839 | 934 | 1,012 | 1,533 | 1,659 | 1,735 |
901 | 836 | 961 | 863 | 884 | 686 | 664 | 568 | 382 | 295 | 47 | 73 | 121 | |
129 | 145 | 160 | 141 | 123 | 142 | 192 | 167 | 222 | 551 | 386 | 583 | 283 | |
Total Liabilities | 1,275 | 1,258 | 1,422 | 1,333 | 1,371 | 1,608 | 1,697 | 1,606 | 1,570 | 1,890 | 2,000 | 2,350 | 2,174 |
172 | 172 | 182 | 159 | 163 | 191 | 200 | 205 | 200 | 226 | 251 | 263 | 267 | |
CWIP | 8 | 9 | 10 | 17 | 4 | 3 | 18 | 5 | 22 | 11 | 7 | 8 | 24 |
Investments | 58 | 60 | 62 | 62 | 65 | 87 | 128 | 128 | 126 | 123 | 315 | 312 | 309 |
1,037 | 1,017 | 1,169 | 1,094 | 1,140 | 1,327 | 1,352 | 1,268 | 1,222 | 1,529 | 1,427 | 1,767 | 1,574 | |
Total Assets | 1,275 | 1,258 | 1,422 | 1,333 | 1,371 | 1,608 | 1,697 | 1,606 | 1,570 | 1,890 | 2,000 | 2,350 | 2,174 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-16 | 163 | -0 | 206 | 88 | -26 | 194 | 200 | 273 | 186 | 127 | 77 | |
-21 | -21 | -36 | -11 | -13 | -68 | -94 | -0 | -38 | -31 | -232 | -21 | |
32 | -138 | 31 | -192 | -78 | 92 | -99 | -201 | -234 | -147 | 94 | -39 | |
Net Cash Flow | -4 | 4 | -5 | 3 | -3 | -2 | 1 | -1 | 1 | 8 | -10 | 17 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 61 | 52 | 39 | 54 | 58 | 60 | 52 | 38 | 20 | 30 | 18 | 20 |
Inventory Days | 185 | 175 | 168 | 179 | 155 | 185 | 188 | 164 | 194 | 198 | 138 | 163 |
Days Payable | 24 | 24 | 19 | 20 | 14 | 22 | 28 | 22 | 36 | 86 | 39 | 59 |
Cash Conversion Cycle | 222 | 203 | 188 | 213 | 199 | 223 | 212 | 180 | 178 | 141 | 117 | 124 |
Working Capital Days | 187 | 166 | 191 | 179 | 174 | 194 | 187 | 164 | 146 | 119 | 93 | 103 |
ROCE % | 12% | 11% | 11% | 11% | 13% | 10% | 11% | 12% | 13% | 13% | 16% | 14% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
18 Nov - Schedule of analysts/investors meeting on November 21, 2024.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 14 Nov
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
12 Nov - Of Schedule of Analysts / Institutional Investor's meeting(s) / conference(s).
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
11 Nov - Schedule of Analyst/Investor meetings on November 19, 2024.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
11 Nov - Of Schedule of Analysts / Institutional Investor's meeting(s) / conference(s).
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
Oct 2024Transcript PPT REC
-
Oct 2024TranscriptNotesPPT
-
Jul 2024Transcript PPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT
-
Oct 2023Transcript PPT REC
-
Jul 2023TranscriptNotesPPT
-
May 2023Transcript PPT
-
Jan 2023TranscriptNotesPPT
-
Jan 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Oct 2022TranscriptNotesPPT
-
Jul 2022TranscriptNotesPPT
-
Jun 2022Transcript PPT
-
Jan 2022TranscriptNotesPPT
-
Dec 2021TranscriptNotesPPT
-
Oct 2021Transcript PPT
-
Jul 2021TranscriptNotesPPT
-
May 2021Transcript PPT
-
Jan 2021Transcript PPT
-
Oct 2020Transcript PPT
-
Jul 2020Transcript PPT
-
May 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Aug 2019Transcript PPT
-
May 2019Transcript PPT
-
Mar 2019TranscriptNotesPPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Sep 2018TranscriptNotesPPT
-
Aug 2018TranscriptNotesPPT
-
Aug 2018Transcript PPT
-
Aug 2018TranscriptNotesPPT
-
May 2018Transcript PPT
-
Feb 2018Transcript PPT
-
Nov 2017Transcript PPT
-
Aug 2017Transcript PPT
-
May 2017Transcript PPT
-
Feb 2017Transcript PPT
-
Nov 2016Transcript PPT
-
Aug 2016TranscriptNotesPPT
-
May 2016Transcript PPT
-
Feb 2016Transcript PPT
-
Jan 2016TranscriptNotesPPT
-
Dec 2015TranscriptNotesPPT
Brands
The company owns several rice brands such as Daawat, Royal, Heritage, Devaaya, Gold Seal Indus Valley, 817 Elephant and Kari Kari and Ecolife. [1]. Its flagship Brands “Daawat” and “Royal” enjoy leadership positions in the market of Basmati Rice in India and North America with market share of 30% and 50% respectively. [2]